hypoxanthine has been researched along with Fetal Growth Restriction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, RH; Beaudin, AE; Perry, CA; Stabler, SP; Stover, PJ | 1 |
| Araki, T; Kubonoya, K; Otsubo, Y; Power, GG; Sawa, R; Suzuki, S; Yoneyama, Y | 1 |
2 other study(ies) available for hypoxanthine and Fetal Growth Restriction
| Article | Year |
|---|---|
Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice.
Topics: Aminohydrolases; Animals; Choline; Choline Deficiency; Crosses, Genetic; Disease Models, Animal; Embryo Loss; Female; Fetal Growth Retardation; Folic Acid; Folic Acid Deficiency; Formate-Tetrahydrofolate Ligase; Genes, Lethal; Heterozygote; Homocysteine; Hypoxanthine; Maternal Nutritional Physiological Phenomena; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Mutant Strains; Multienzyme Complexes; Mutagenesis, Insertional; Neural Tube Defects; Pregnancy | 2012 |
Fetal plasma hypoxanthine level in growth-retarded fetuses before labor.
Topics: Acid-Base Equilibrium; Adult; Female; Fetal Blood; Fetal Diseases; Fetal Growth Retardation; Fetus; Humans; Hypoxanthine; Hypoxia; Labor, Obstetric; Pregnancy; Umbilical Veins | 1997 |